Human Peripheral Blood Market

Peripheral blood is the blood circulating throughout the body. The cellular components that could be isolated from human peripheral blood include erythrocytes (red blood cells), leukocytes (white blood cells), and thrombocytes (platelets). Plasma, the liquid component of peripheral blood, can also be collected and it is the vehicle through which these blood cells circulate the body. The highly dynamic peripheral blood cell composition and its importance in studying the immune system coupled with the noninvasive and easily accessible collection methods of its WBC population have made it the most widely used system in research and therapy development.

The popularity of human peripheral blood in research is because of its white blood cell (WBC) population, notably peripheral blood mononuclear cells (PBMCs) which include subsets from the lymphoid lineage (T cells, B cells, NK cells) and myeloid lineage (monocytes, dendritic cells). These WBCs are critical components of the innate and adaptive immune response and are the main building blocks for development of many cell therapies such as CAR-T.
Human Peripheral Blood Market contains market size and forecasts of Human Peripheral Blood in Global, including the following market information:
Global Human Peripheral Blood Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global Human Peripheral Blood market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Unprocessed Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Human Peripheral Blood include Charles River, StemExpress, AllCells, Lonza, iSpecimen, Cytologics and ATCC, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Human Peripheral Blood companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Peripheral Blood Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Human Peripheral Blood Market Segment Percentages, by Type, 2022 (%)
Unprocessed
Primary Cells
Others
Global Human Peripheral Blood Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Human Peripheral Blood Market Segment Percentages, by Application, 2022 (%)
Disease Treatment
Research and Development
Others
Global Human Peripheral Blood Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Human Peripheral Blood Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Human Peripheral Blood revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Human Peripheral Blood revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Charles River
StemExpress
AllCells
Lonza
iSpecimen
Cytologics
ATCC